Invokana lawyers are filing Invokana lawsuits for Ketoacidosis, heart attack, diabetic coma and deaths.
Invokana is an SGLT2 inhibitor that may lead to ketoacidosis. The FDA has issued warnings that
Have been shown to cause serious medical conditions including:
The Invokana lawyers at Class Action Lawyer Network are filing lawsuits on behalf of patients who suffered serious injuries after taking:
Xigduo XR (dapagliflozin/metformin)
The FDA Issued A Warning For Invokana
In May 2015, the FDA warned that Invokana may put patients at risk for ketoacidosis. Ketoacidosis may cause diabetic comas or death.
The Dangers Of Invokana Resulting In Lawsuits
Our Invokana lawyers are filing lawsuits claiming the manufacturer failed to warn patients and doctors of the risks of kidney failure, myocardial infarction, and ketoacidosis Invokana os a medication given to diabetics to help lower blood sugar.
Invokana Class Action Lawyers
Our Invokana lawyers are filing Invokana lawsuits for kidney damage,heart attacks, and ketoacidosis complications from the medication Invokana. Lawsuits are being filed because the manufacturers and of SGLT2 inhibitors (such as Johnson & Johnson, Janssen Pharmaceuticals Inc., AstraZeneca & Boehringer Ingelheim) failed to warn patients and physicians of the risks of kidney failure, myocardial infarction and ketoacidosis.
What is Invokana?
You may have been prescribed Invokana to improve glycemic control and lower blood sugar if you are a type 2 diabetic. These medications lower a person’s blood sugar by causing the kidneys to remove it through the urine.
Heart Attack Ketoacidosis Drugs
Canagliflozin and Metformin,
Dapagliflozin and Metformin extended-release,
Empagliflozin and Linagliptin.
Risks Alert For Kidney Failure
Kidney failure occurs when your kidneys stop functioning. When your kidneys stop properly functioning, you will experience cause weakness, shortness of breath, lethargy, confusion, abnormal heart rhythms and even sudden death.
Risk Alert For Heart Attacks
A heart attack results in the death of cells within the heart. This is caused by a restriction of blood. It occurs when there is a blockage in the arteries preventing blood from reaching portions the heart.
Risk Alert For Ketoacidosis
Ketoacidosis is high levels of ketones. Ketoacidosis can result in a patient suffering a diabetic coma, extended hospitalization and even death. The FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood. Medications in the class include AstraZeneca’s Farxiga and Xigduo, Jardiance and Glyxambi from Lilly and Boehringer Ingelheim. J&J also combines the active ingredient in Invokana with metformin and markets it as Invokamet.
Speak to one of our Invokana lawyers today